Panic Attack Treatment Market Report 2026

Panic Attack Treatment Market Overview

• Panic Attack Treatment market size has reached to $3.58 billion in 2025 • Expected to grow to $7.97 billion in 2030 at a compound annual growth rate (CAGR) of 17.3% • Growth Driver: The Increasing Prevalence Of Anxiety Is Driving The Panic Attack Treatment Market Due To Rising Stress • Market Trend: Next-Gen Digital Platform Transforms Anxiety And Panic Attack Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the panic attack treatment market include: • Cognitive Behavioral Therapy (CBT) (Segmentation By Treatment Type) → Expected gain of $1.67 Billion • Medications (Segmentation By Treatment Type) → Expected gain of $1.62 Billion • Other Treatment Types (Segmentation By Treatment Type) → Expected gain of $1 Billion

What Is Covered Under Panic Attack Treatment Market?

Panic attack treatment refers to a range of professionally administered medical and psychological interventions developed to manage, reduce, and prevent the occurrence of sudden, intense episodes of fear or discomfort characterized by physical and emotional distress. These treatments are used to restore emotional stability, minimize disruption to daily functioning, and support long-term mental well-being in individuals affected by panic-related disorders. The main treatment types for panic attack treatment are cognitive behavioral therapy (CBT), medications, and others. Cognitive behavioral therapy (CBT) is a structured, time-limited psychotherapeutic approach used in panic attack treatment that helps individuals identify and change negative thought patterns and behaviors that trigger or worsen anxiety symptoms. The drug classes used in these treatments are antidepressants, anti-anxiety drugs, calcitonin gene-related peptide (CGRP) antagonists, and others, which are administered through various routes such as oral, intravenous, intramuscular, sublingual, and others, distributed by channels including hospital pharmacies, retail pharmacies, and online pharmacies, and used in applications such as hospitals, mental healthcare centers, and others.

What Is The Panic Attack Treatment Market Growth Forecast?

The panic attack treatment market size is expected to see rapid growth in the next few years. It will grow to $7.97 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of telehealth platforms, growth in virtual reality and digital therapeutics, rising prevalence of anxiety and panic disorders, advancements in personalized medicine, expansion of online pharmacy and hospital distribution channels. Major trends in the forecast period include rising adoption of telepsychiatry and mobile health applications, integration of virtual reality therapy for panic disorders, increasing use of neurofeedback and biofeedback techniques, growth in personalized medication plans, expansion of mental healthcare centers and hospital services.

What Is The Driver Of The Panic Attack Treatment Market?

The increasing prevalence of anxiety is expected to propel the growth in the panic attack treatment market going forward. Anxiety is a mental health condition characterized by persistent feelings of worry, nervousness, and fear, often accompanied by physical symptoms such as restlessness, rapid heartbeat, and difficulty concentrating. The pressures of modern life contribute to rising anxiety levels by creating constant demands for productivity, financial stability, and social success, leaving little time for rest or emotional recovery. Panic attack treatment addresses anxiety by offering effective solutions to alleviate symptoms, improve emotional well-being, and help individuals regain control of their lives through personalized and timely interventions. For instance, in May 2024, according to the American Psychiatric Association (APA), a US-based medical specialty society representing psychiatrists nationwide, a growing percentage of U.S. adults report feeling more anxious, with 43% in 2024 expressing higher anxiety levels compared to 37% in 2023 and 32% in 2022. Therefore, the increasing prevalence of anxiety is driving the panic attack treatment industry.

How Will The Drivers Impact Growth In The Global Panic Attack Treatment Market?

• Rising Prevalence Of Anxiety And Panic Disorders (High) – During the forecast period, the rising prevalence of anxiety and panic disorders is expected to become a primary growth driver for the panic attack treatment market by 2030. Increasing exposure to high-stress lifestyles, urbanization, and socio-economic pressures is contributing to a growing patient pool requiring clinical intervention. This expanding burden of panic-related conditions is encouraging healthcare systems to scale diagnostic and treatment capabilities, including early screening and intervention programs. Additionally, higher reporting rates and improved clinical recognition are further strengthening demand for effective treatment solutions. • Increasing Awareness And Reduced Mental Health Stigma (High) – During the forecast period, the increasing awareness and reduced mental health stigma is expected to emerge as a major factor driving the expansion of the panic attack treatment market by 2030. Public health campaigns, educational initiatives, and advocacy efforts are encouraging individuals to seek timely medical support for panic-related conditions. This cultural shift is improving treatment-seeking behavior and increasing acceptance of both psychological therapies and pharmacological interventions. Furthermore, social media influence and community-based outreach programs are playing a critical role in normalizing mental health discussions. • Advancements In Treatment Options And Accessibility (Medium) – During the forecast period, advancements in treatment options and accessibility are expected to act as a key growth catalyst for the panic attack treatment market by 2030. Innovations such as digital mental health platforms, remote therapy solutions, and improved drug formulations are enhancing treatment reach and patient convenience. The integration of technology-driven solutions is enabling continuous monitoring, personalized therapy, and better adherence to treatment plans. In addition, expanding healthcare infrastructure and improved access in emerging markets are supporting broader patient coverage.

How Will The Restraints Impact Growth In The Global Panic Attack Treatment Market?

• Shortage Of Mental Health Professionals (High) – During the forecast period, shortage of mental health professionals is restricting the growth of the panic attack treatment market. Limited availability of trained psychiatrists, psychologists, and therapists is creating gaps in diagnosis and treatment access, thereby limiting timely care for patients • Lack Of Skilled Workforce And Technical Expertise (High) – During the forecast period, lack of skilled workforce and technical expertise is restricting the growth of the panic attack treatment market. Insufficient training in advanced therapeutic approaches and digital mental health tools is hindering effective treatment delivery and patient outcomes • Social Stigma And Underreporting Of Mental Health Conditions (Medium) – During the forecast period, social stigma and underreporting of mental health conditions are restricting the growth of the panic attack treatment market. Negative perceptions and reluctance to seek professional help are reducing diagnosis rates and limiting overall treatment adoption

Key Players In The Global Panic Attack Treatment Market

Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann‑La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol‑Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., Cipla Limited

Global Panic Attack Treatment Market Trends and Insights

Major companies operating in the panic attack treatment market are focusing on developing advancements in medical technology, such as digital anxiety relief platforms, to enhance the management of anxiety and panic attacks through accessible, technology-driven solutions. Digital anxiety relief platforms are technology-based applications or services designed to help individuals manage and reduce anxiety through tools such as guided meditation, cognitive behavioral therapy modules, mood tracking, and relaxation exercises. For instance, in October 2024, CalmiGo, a US-based mental health startup, launched CalmiGo Plus, an advanced digital platform designed to support users in managing anxiety and panic attacks more effectively. The platform includes a patented, sensor-based exhaler device and a companion mobile application that leverages gamification and personalized therapeutic techniques to improve mental health outcomes. This innovation enables users to receive immediate, drug-free relief while also tracking progress over time, reflecting a significant step forward in accessible and data-driven anxiety treatment solutions.

What Are Latest Mergers And Acquisitions In The Panic Attack Treatment Market?

In August 2024, AbbVie Inc., a US-based biopharmaceutical company, acquired Cerevel Therapeutics for $8.7 billion. With this acquisition, AbbVie aimed to expand its neuroscience portfolio by gaining access to Cerevel Therapeutics’ promising pipeline of treatments for psychiatric and neurological disorders, including anxiety and panic-related conditions. Cerevel Therapeutics is a US-based clinical-stage biopharmaceutical company focused on developing therapies for neuroscience diseases, including panic attacks.

What Defines the Panic Attack Treatment Market?

The panic attack treatment market consists of revenues earned by entities by providing services such as exposure therapy sessions, dialectical behavior therapy, telepsychiatry and remote consultation services, mental wellness subscription platforms, supportive counseling and peer group therapy, and personalized mental health coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic attack treatment market also includes sales of biofeedback and neurofeedback devices, virtual reality-based therapy solutions, mobile mental health applications, genetic testing kits for psychiatric profiling, mental health diagnostic and screening tools, wearable devices for anxiety monitoring, AI-powered therapeutic chatbots, and digital therapeutic platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Panic Attack Treatment Market Report 2026?

The panic attack treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the panic attack treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.